FDA approves new drug for Chronic Lymphocytic Leukemia

The FDA has recently approved the drug Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL).This is good news since nearly 16,000 cases of CLL are diagnosed each year.See reference for full story on the drug.


Reference

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187966.htm